Cannabis Law Report

OCTOBER 29, 2019

ElleVet Sciences is pleased to announce the results and publication of the first safety study on the use of hemp CBD/CBDA. The 12-week safety study, conducted by Dr. Joseph Wakshlag, DVM, Ph.D., Dr. Wakshlag is currently available for interviews to discuss the results of the safety study as well as his clinical trials.

Safety 45

Safety CBD Clinical Trials Oil 45

SpeedWeed

JULY 30, 2021

Before adult-use legalization, Coloradans legalized medical cannabis through a 2000 ballot measure. Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . in 2013 to 35.9% 10, 2012, when Gov. rate in 2019.

Business 52

Business Data Safety Cannabinoids 52

SpeedWeed

JULY 30, 2021

Before adult-use legalization, Coloradans legalized medical cannabis through a 2000 ballot measure. Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . in 2013 to 35.9% 10, 2012, when Gov. rate in 2019.

Retail 52

Retail Data Safety Cannabinoids 52

SpeedWeed

JULY 31, 2021

Before adult-use legalization, Coloradans legalized medical cannabis through a 2000 ballot measure. Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . in 2013 to 35.9% 10, 2012, when Gov. rate in 2019.

Legalization 52

Legalization Data Safety Cannabinoids 52

SpeedWeed

JULY 30, 2021

Before adult-use legalization, Coloradans legalized medical cannabis through a 2000 ballot measure. Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . in 2013 to 35.9% 10, 2012, when Gov. rate in 2019.

Data 52

Data Safety Cannabinoids Cannabis 52

SpeedWeed

JULY 30, 2021

Before adult-use legalization, Coloradans legalized medical cannabis through a 2000 ballot measure. Data going back to 2005 is included in the commissioned report on the impacts of legalization, which was mandated by the Colorado General Assembly in 2013. . in 2013 to 35.9% 10, 2012, when Gov. rate in 2019.

Dispensary 52

Dispensary Data Safety Cannabinoids 52

Cannabis Law Report

APRIL 8, 2022

This year, we are completing the second Phase 3 clinical trial of MDMA-assisted therapy for PTSD , the final stage prior to requesting FDA approval for a new prescription treatment to help heal trauma. MAPS completed the first Phase 1 safety study with MDMA and resumed working on a protocol for anxiety associated with cancer.

Clinical Trials 52

Clinical Trials Therapy Research and Development DEA 52